Correlation Between Madrigal Pharmaceuticals and Agenus

Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Madrigal Pharmaceuticals and Agenus Inc, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Agenus.

Diversification Opportunities for Madrigal Pharmaceuticals and Agenus

-0.62

Correlation Coefficient

Madrigal Pharmaceuticals  Agenus

Excellent diversification

The 3 months correlation between Madrigal and Agenus is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Agenus go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Agenus

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to under-perform the Agenus. But the stock apears to be less risky and, when comparing its historical volatility, Madrigal Pharmaceuticals is 1.23 times less risky than Agenus. The stock trades about -0.06 of its potential returns per unit of risk. The Agenus Inc is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest  272.00  in Agenus Inc on October 22, 2024 and sell it today you would earn a total of  76.00  from holding Agenus Inc or generate 27.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Madrigal Pharmaceuticals  vs.  Agenus Inc

Madrigal Pharmaceuticals

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Agenus Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Madrigal Pharmaceuticals and Agenus

The main advantage of trading using opposite Madrigal Pharmaceuticals and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.

The idea behind Madrigal Pharmaceuticals and Agenus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.